Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APD-209 in Acute Adenoviral Epidemic Keratoconjunctivitis
NCT01977443Phase 2Completed
- Sponsor
- Adenovir Pharma
- Start
- Nov 2013
- Primary completion
- Sep 2016
- Countries
- 3
01
Overview
A Phase 2 trial of APD-209 Placebo Eye drops in epidemic keratoconjunctivitis (EKC), sponsored by Adenovir Pharma. Started Nov 2013; status: completed.
02
Drugs
APD-209 Placebo Eye drops
03
Conditions
epidemic keratoconjunctivitis (EKC)
Beyond the preview
Go deeper on NCT01977443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01977443.